submit to the journals

Johann S De Bono

Division of Clinical Studies, The Institute of Cancer Research, Sutton, UK; Prostate Cancer Targeted Therapy Group, The Royal Marsden NHS Foundation Trust Sutton, UK

Authored articles:

Improving the Outcome of Patients with Castration-resistant Prostate Cancer Through Rational Targeting of the Androgen Receptor
Chris Parker, Johann S De Bono, Gerhardt Attard
European Oncology & Haematology
European Oncology, 2009;5(1):58-63 DOI: http://doi.org/10.17925/EOH.2009.05.1.58
Should we Address Biochemical Recurrence of Prostate Cancer as Soon as Possible? Against
Robert Chandler, Antonella Petremolo, Pasquale Rescigno, Johann S De Bono
European Oncology & Haematology
European Oncology & Haematology. 2018;14(1):14–15 DOI: https://doi.org/10.17925/EOH.2018.14.1.14
Targeted Alpha Therapy – Optimising Survival in Advanced Prostate Cancer
Johann S De Bono
European Oncology & Haematology
European Oncology & Haematology. 2018;14(Suppl 3);3–10

Out Now